Patents | Stilla Technologies

Stilla Technologies is a leading provider of Digital PCR products, which incorporate unique patented features.

This page is intended to serve as notice under 35 U.S.C. § 287(a).

Name	Product Number	Patent Information
Geode	H10000 H11000 H12000 H13000 H14000 H15000	US 10,632,465, US 11,577,242, other US patents pending, and foreign patents and patent applications
Prism6	H24000	Patents pending
Crystal Miner Software	S20000	US and foreign patents pending
Sapphire Chip	C13000 C13001 C13002 C13003 C13004 C13005 C13006 C14012 C14024 C14036 C14048 C14060 C14072	US 9,133,009, US 9,816,133, US 10,501,789, US 12,071,658, other US patents pending, and foreign patents and patent applications
Ruby Chip	C16011	US 9,133,009, US 9,816,133, US 10,501,789, US11,066,699, US 12,071,658, other US patents pending, and foreign patents and patent applications
Opal Chip	C15001	US 9,133,009, US 9,816,133, US 10,501,789, US11,066,699, US 12,071,658, other US patents pending, and foreign patents and patent applications
Nio® Digital PCR, (Nio® E, Nio®, Nio®+)	N30027 N30027.0 N30027.1 N30027.2	US 10,632,465, US 11,577,242, other US patents pending, and foreign patents and patent applications
Crystal Digital PCR® Assays, Crystal Flex Probes and Crystal Universal Reporters 3, Crystal Universal Reporters 7	R5xxxx.1 R5xxxx.2 R6xxxx R41401 R41402 R42401 R42402	Patents pending
Nio® Reader software, Nio® Analyzer software	S40000 S40021 S50000 S50021	International Design DM/238908, Chinese design patent No. ZL 2023 3 0731964.3

Licensed patents:

The naica® system and/or its use is licensed under U.S. and/or non-U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc., including, but not limited to, U.S. Patent Nos. 9,968,933; 9,127,310; RE41,780; and 8,871,444. Purchase of the naica® system includes a limited, non-transferable right under such intellectual property for use of the products for research and applied applications, including commercial services, but excluding any commercial NIPT services. The exclusion of commercial NIPT services applies only in the United States and the European Union. It is the responsibility of the purchaser/end user to acquire any additional intellectual property rights that may be required from Bio-Rad Laboratories, Inc.
EP2964787; EP3418398; CN105189785; US9822393; US10676778; US9921154; CN105074012; EP2951320; US9217175; US9845496; EP2951337; CN105074060; CN105492455; EP2970367; US9970052; US20180251817; US10512910; GB2477053; EP2347245; US20190255531; EP2686449; US9222128; US9,523,116; US8951939; EP2673380; US10167509; US9127312; US20190241947; EP3483285; CN103562407; JP2014506465; CA2826748; EP2888375; US9702822; US9074242; US9441266; US9127310; US9745617; US20180057863; EP3392349; EP2844768; US9399797; EP3524693; US9458511; DE202012013668; US2020/0249230; EP3782722; EP2971117; JP6825044; US2020/0360876; US9427737; US2021/0002703; USRE41780; US8871444; EP2270236; JP5903067; U.S. Patent App. No. 10/961,695; EP2278338; EP3290921; US8889083; US9968933; US10668471; US9839893; US10118174; EP2283918

The naica® system and/or its use is licensed under U.S. and/or non-U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc., including, but not limited to, U.S. Patent Nos. 9,968,933; 9,127,310; RE41,780; and 8,871,444. Purchase of the naica® system includes a limited, non-transferable right under such intellectual property for use of the products for research and applied applications, including commercial services, but excluding any commercial NIPT services. The exclusion of commercial NIPT services applies only in the United States and the European Union. It is the responsibility of the purchaser/end user to acquire any additional intellectual property rights that may be required from Bio-Rad Laboratories, Inc.

EP2964787; EP3418398; CN105189785; US9822393; US10676778; US9921154; CN105074012; EP2951320; US9217175; US9845496; EP2951337; CN105074060; CN105492455; EP2970367; US9970052; US20180251817; US10512910; GB2477053; EP2347245; US20190255531; EP2686449; US9222128; US9,523,116; US8951939; EP2673380; US10167509; US9127312; US20190241947; EP3483285; CN103562407; JP2014506465; CA2826748; EP2888375; US9702822; US9074242; US9441266; US9127310; US9745617; US20180057863; EP3392349; EP2844768; US9399797; EP3524693; US9458511; DE202012013668; US2020/0249230; EP3782722; EP2971117; JP6825044; US2020/0360876; US9427737; US2021/0002703; USRE41780; US8871444; EP2270236; JP5903067; U.S. Patent App. No. 10/961,695; EP2278338; EP3290921; US8889083; US9968933; US10668471; US9839893; US10118174; EP2283918